Company Filing History:
Years Active: 2005-2009
Title: **Innovator Frank P. Luyten: Pioneering Tissue Growth Modulation**
Introduction
Frank P. Luyten, based in Rockville, MD, is a distinguished inventor with a remarkable portfolio comprising five patents. His groundbreaking contributions primarily focus on enhancing tissue growth and repair, specifically in the fields of bone, cartilage, muscle, and nerve tissue.
Latest Patents
Luyten's latest patents showcase his innovative approaches in the biomedical field. One notable patent details a "Method of Modulating Tissue Growth Using Frzb Protein." This patent introduces an isolated cDNA encoding the growth-inducing protein, Frzb, capable of stimulating the formation of various tissues. Frzb functions by binding to and modulating the activity of Wnt growth factors, which are crucial in numerous developmental and neoplastic processes. Additionally, the patent provides the cDNA and protein sequences of human and bovine Frzb, along with the methods for producing and purifying recombinant Frzb.
Another significant patent focuses on "Cartilage-Derived Morphogenetic Proteins," where Luyten outlines the nucleotide and amino acid sequences of cartilage-derived morphogenetic proteins (CDMP-1 and CDMP-2) obtained from human and bovine cartilage extracts. These proteins have demonstrated chondrogenic activity and hold potential for repairing cartilage defects in mammals, marking a considerable advancement in regenerative medicine.
Career Highlights
Currently, Frank P. Luyten is associated with the Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services. His work in this esteemed organization underscores his commitment to advancing health sciences and improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Luyten has collaborated with notable colleagues, including Malcolm Moos, Jr. and Bang Hoang. These partnerships highlight the interdisciplinary nature of his work, combining expertise from various fields to foster innovation in tissue engineering and regenerative medicine.
Conclusion
Frank P. Luyten's contributions to the field of biomedical innovation are invaluable. His latest patents reflect a deep commitment to understanding and manipulating biological processes for the betterment of human health. As he continues to innovate, the potential impact of his work may lead to revolutionary treatments in regenerative medicine, solidifying his position as a pivotal figure in the development of tissue growth modulation technologies.